Literature DB >> 16162207

A surveillance study of adenovirus infection in adult solid organ transplant recipients.

Atul Humar1, Deepali Kumar, Tony Mazzulli, Raymund R Razonable, George Moussa, Carlos V Paya, Emma Covington, Emma Alecock, Mark D Pescovitz.   

Abstract

Little is known about adenovirus infections in adult organ transplant recipients. We prospectively assessed adenovirus infection in 263 transplant recipients using polymerase chain reaction (PCR) on plasma samples at regular intervals post-transplant. Adenovirus DNA was detected in 19 of 263 patients (7.2%). Viremia by transplant type was: liver (n = 10 of 121 [8.3%]), kidney (n = 6 of 92 [6.5%]) and heart (n = 3 of 45 [6.7%]). Time to viremia onset was within 10 days post-transplant (n = 4), on day 28 (n = 1), on day 100 (n = 7) and between months 6 and 12 (n = 7). At the time of viremia, 11 of 19 (58%) patients had no symptoms, 2 of 19 (10.5%) had gastrointestinal (GI) symptoms, 2 of 19 (10.5%) had respiratory symptoms and 4 patients (21%) had vague/non-specific symptoms. All patients recovered spontaneously. Only 1 of 19 (5%) patients had subsequent acute rejection. Adenovirus viremia is relatively common in adult liver, kidney and heart transplant recipients and most infections are asymptomatic, transient and self-limited. No serious clinical sequelae or effects on subsequent acute rejection were observed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16162207     DOI: 10.1111/j.1600-6143.2005.01033.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  31 in total

1.  Late presentation of adenovirus-induced hemorrhagic cystitis and ureteral obstruction in a kidney-pancreas transplant recipient.

Authors:  Jeffrey Klein; Michael Kuperman; Clinton Haley; Yousri Barri; Arun Chandrakantan; Bernard Fischbach; Larry Melton; Kim Rice; Muhammad Saim; Angelito Yango; Goran Klintmalm; Arthi Rajagopal
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-10

Review 2.  Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients.

Authors:  S Samuel Weigt; Aric L Gregson; Jane C Deng; Joseph P Lynch; John A Belperio
Journal:  Semin Respir Crit Care Med       Date:  2011-08-19       Impact factor: 3.119

Review 3.  Adenovirus infections in immunocompetent and immunocompromised patients.

Authors:  Thomas Lion
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

4.  Adenovirus: current epidemiology and emerging approaches to prevention and treatment.

Authors:  Uriel Sandkovsky; Luciano Vargas; Diana F Florescu
Journal:  Curr Infect Dis Rep       Date:  2014-08       Impact factor: 3.725

5.  Inhibition of adenovirus replication by a trisubstituted piperazin-2-one derivative.

Authors:  Javier Sanchez-Cespedes; Crystal L Moyer; Landon R Whitby; Dale L Boger; Glen R Nemerow
Journal:  Antiviral Res       Date:  2014-06-04       Impact factor: 5.970

Review 6.  Beyond Cytomegalovirus and Epstein-Barr Virus: a Review of Viruses Composing the Blood Virome of Solid Organ Transplant and Hematopoietic Stem Cell Transplant Recipients.

Authors:  Marie-Céline Zanella; Samuel Cordey; Laurent Kaiser
Journal:  Clin Microbiol Rev       Date:  2020-08-26       Impact factor: 26.132

7.  Brincidofovir (CMX001) for the Treatment of Severe Adenoviral Pneumonia in Kidney Transplant Recipient.

Authors:  Praveen Sudhindra; Bettina Knoll; Rajat Nog; Nandita Singh; Abhay Dhand
Journal:  Cureus       Date:  2019-08-01

8.  Adenovirus disease in six small bowel, kidney and heart transplant recipients; pathology and clinical outcome.

Authors:  Vikas Mehta; Pauline C Chou; Maria M Picken
Journal:  Virchows Arch       Date:  2015-09-16       Impact factor: 4.064

Review 9.  Adenoviruses in immunocompromised hosts.

Authors:  Marcela Echavarría
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

10.  Prospective Assessment of Adenovirus Infection in Pediatric Kidney Transplant Recipients.

Authors:  Rachel M Engen; Meei-Li Huang; Giulia E Park; Jodi M Smith; Ajit P Limaye
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.